Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 184.50
-7.50 (-3.91%)
Mar 9, 2026, 1:30 PM CST
Alar Pharmaceuticals Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 12,325 | 9,452 | 11,942 | 6,555 | 2,608 | 2,793 | Upgrade
|
| Market Cap Growth | 25.94% | -20.85% | 82.17% | 151.37% | -6.63% | - | Upgrade
|
| Enterprise Value | 9,990 | 7,028 | 11,326 | 6,046 | 2,053 | 2,171 | Upgrade
|
| Last Close Price | 184.50 | 141.26 | 208.00 | 114.18 | 45.42 | 48.65 | Upgrade
|
| PE Ratio | - | 520.21 | 31.21 | - | - | - | Upgrade
|
| PS Ratio | 9836.07 | 1624.93 | 25.45 | 8193.75 | - | 4655.00 | Upgrade
|
| PB Ratio | 5.09 | 3.79 | 13.31 | 12.74 | 4.88 | 4.67 | Upgrade
|
| P/TBV Ratio | 5.09 | 3.79 | 13.31 | 12.74 | 4.88 | 4.67 | Upgrade
|
| P/FCF Ratio | - | - | 30.06 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 29.59 | - | - | - | Upgrade
|
| EV/Sales Ratio | - | 1208.22 | 24.14 | 7557.22 | - | 3617.60 | Upgrade
|
| EV/EBITDA Ratio | - | - | 29.22 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 29.38 | - | - | - | Upgrade
|
| EV/FCF Ratio | -112.38 | - | 28.51 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0 | 0.00 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.00 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 0.00 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.96 | -0.97 | -1.00 | -0.94 | -0.97 | -0.93 | Upgrade
|
| Net Debt / EBITDA Ratio | 18.19 | 37.14 | -2.31 | 10.95 | 5.71 | 3.32 | Upgrade
|
| Net Debt / FCF Ratio | 26.27 | 34.80 | -2.25 | 14.19 | 7.97 | 3.93 | Upgrade
|
| Asset Turnover | 0 | 0.00 | 0.63 | 0.00 | - | 0.00 | Upgrade
|
| Quick Ratio | 26.06 | 44.14 | 11.98 | 90.70 | 116.51 | 135.92 | Upgrade
|
| Current Ratio | 26.49 | 44.33 | 12.08 | 92.66 | 118.67 | 143.31 | Upgrade
|
| Return on Equity (ROE) | -1.20% | 1.07% | 54.21% | -3.79% | -11.34% | -36.17% | Upgrade
|
| Return on Assets (ROA) | -3.24% | -2.41% | 32.22% | -5.47% | -10.20% | -26.68% | Upgrade
|
| Return on Invested Capital (ROIC) | -135.76% | -104.19% | 2250.88% | -197.02% | -336.68% | -556.61% | Upgrade
|
| Return on Capital Employed (ROCE) | -5.40% | -2.70% | 42.90% | -9.00% | -17.40% | -28.50% | Upgrade
|
| Earnings Yield | -0.24% | 0.19% | 3.20% | -0.30% | -2.46% | -5.11% | Upgrade
|
| FCF Yield | -0.72% | -0.74% | 3.33% | -0.52% | -2.49% | -5.10% | Upgrade
|
| Dividend Yield | 0.13% | 0.18% | 0.72% | - | - | - | Upgrade
|
| Payout Ratio | - | 551.46% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -4.69% | -16.08% | -0.09% | - | -14.21% | -42.59% | Upgrade
|
| Total Shareholder Return | -4.56% | -15.90% | 0.63% | - | -14.21% | -42.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.